title: Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment.
abstract: Acute fulminant fungal sinusitis is characterized by acute symptoms and rapid progress with a mortality rate of 60-80%. A large number of survivors have permanent neurological, visual and cosmetic disabilities. This clearly underscores the need of early recognition of this disease in at risk population in order to start urgent treatment. The at-risk population of diabetics, AIDS and other immunosuppressed is likely to increase, as will the incidence of acute fulminant fungal sinusitis. In the present study we have reviewed nine cases of acute fulminant fungal sinusitis to determine clinical presentation, related radiological picture and optimum treatment. Most common presenting features were fever, headache, facial swelling and proptosis. Many patients presented with blindness, facial paralysis and meningitis. Predisposing causes were uncontrolled diabetes with ketoacidosis in four out of six cases, post renal transplant immunosuppression and leukemia. All patients were treated with amphotericin B or liposomal amphotericin B (AmBisome). Diagnosis was confirmed by biopsy and culture of sinus mucosa, soft tissues of cheek, or orbit. Mucor (Zygomycetes) was identified on culture or histopathology in all cases. Surgical debridement was performed in seven cases. Six out of nine patients survived but morbidity was high: only two patients survived without any permanent disability.
authors.affiliation: ENT Department, Al Nahdha Hospital, P.O. Box 937, Postal Code 112, Sultanate of Oman, Oman.
authors.forename: M A
authors.initials: MA
authors.lastname: Sohail
authors.forename: M
authors.initials: M
authors.lastname: Al Khabori
authors.forename: J
authors.initials: J
authors.lastname: Hyder
authors.forename: A
authors.initials: A
authors.lastname: Verma
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009089:Mucor / Q000145:classification / Q000302:isolation & purification; D009091:Mucormycosis / Q000000981:diagnostic imaging / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D011859:Radiography; D012189:Retrospective Studies; D012852:Sinusitis / Q000000981:diagnostic imaging / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy
chemical_list: D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B